Skip to main content

PGHL · Procter & Gamble Health Limited · Financials

5,823.70 INR +17.60 (+0.30%) At close · Nov 13
Volume · Nov 13 167 Avg daily vol (3M) 507

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
14.08B
FY2026 Revenue FY2018–FY2026
Net Income
3.27B
FY2026 Net Income FY2018–FY2026
Operating Cash Flow
3.38B
FY2026 Operating Cash Flow FY2021–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2024 FY2023 FY2022 FY2021 FY2018
INR 14.91B 14.08B 11.51B 12.3B 11.14B 10.09B 8.49B
INR 241.7M 235.9M 274M 273.7M 278.1M 300.4M 203.52M
INR 5.8M 5.5M 7.2M 7.7M 4.2M 8M 0
INR 5.21B 4.5B 2.73B 3.14B 2.53B 2.33B 1.58B
INR 1.41B 1.23B 723.4M 847.3M 608.5M 564.8M 562.43M
INR 3.8B 3.27B 2.01B 2.29B 1.93B 1.77B 0
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2026: 15.15B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.